Cannapharmarx's market cap is currently $3.98M. The company's EPS TTM is $-0.001; its P/E ratio is ―; Cannapharmarx is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
